Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Meghan Logun"'
Autor:
Meghan Logun, Maxwell B. Colonna, Katherine P. Mueller, Divya Ventarapragada, Riley Rodier, Chaitanya Tondepu, Nicole J. Piscopo, Amritava Das, Stacie Chvatal, Heather B. Hayes, Christian M. Capitini, Daniel J. Brat, Theresa Kotanchek, Arthur S. Edison, Krishanu Saha, Lohitash Karumbaiah
Publikováno v:
Cytotherapy. 25:670-682
Autor:
Stephen J. Bagley, Zev A. Binder, Arati S. Desai, Maclean P. Nasrallah, Eileen Maloney, Steven Brem, Robert Lustig, Goldie Kurtz, Michelle Alonso-Basanta, Suyash Mohan, Wei-Ting Hwang, Oliver Y. Tang, Meghan Logun, Meghna Bhattacharyya, Kelly Markowitz, Devora Delman, Amy Marshall, Cecile Alanio, Gregory L. Beatty, Jennifer L. Brogdon, Elizabeth Hexner, Donald M. O'Rourke
Treatment efficacy with chimeric antigen receptor (CAR) T cell therapy in glioblastoma (GBM) is undermined by an immunosuppressive tumor microenvironment (TME). We previously showed that CAR T cell therapy targeting epidermal growth factor receptor v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91a30f0fa5828a2c7ff7e2eb9c340b21
https://doi.org/10.21203/rs.3.rs-2742648/v1
https://doi.org/10.21203/rs.3.rs-2742648/v1
Autor:
Nannan Li, Yibo Yin, Jesse Rodriguez, Meghan Logun, Logan Zhan, Jiasi Zhang, Zev A Binder, Zhiguo Lin
Publikováno v:
Neuro-Oncology. 24:vii214-vii214
Chimeric antigen receptor (CAR)-T cells have had a significant effect in hematological diseases, with a recent study confirming that the cells can last for ten years in vivo. Unfortunately, to date, CAR-T cells have had little effect in solid tumors.